News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jenkins John Kenneth
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Jenkins John Kenneth (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 58,200 options to buy
@ $2.07, valued at
$120.5k
|
|
| 05/14/2021 |
4
| Jenkins John Kenneth (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 23,000 options to buy
@ $6.8, valued at
$156.4k
|
|
| 08/11/2020 |
4
| Jenkins John Kenneth (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 128,981 options to buy
@ $12.85, valued at
$1.7M
|
|
| 08/11/2020 |
3
| Jenkins John Kenneth (Director) has filed a Form 3 on Provention Bio, Inc. |
| 05/22/2020 |
4
| Jenkins John Kenneth (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 40,500 options to buy
@ $7.3, valued at
$295.7k
|
|
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2019 |
4
| Jenkins John Kenneth (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Bought 1,000 shares
@ $6.9779, valued at
$7k
|
|
| 06/06/2018 |
4
| Jenkins John Kenneth (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 68,000 options to buy
@ $6, valued at
$408k
|
|
| 06/06/2018 |
3
| Jenkins John Kenneth (Director) has filed a Form 3 on Corbus Pharmaceuticals Holdings, Inc. |
|
|